Abstract：Objective To study the protocol of construction of the mutation E292V and M723I of hABCA3 gene associated with neonatal respiratory distress syndrome, as well as their eukaryotic green fluorescent protein expression rectors, and to examine the expression of mutation proteins in human lung carcinoma epithelial cells (A549). Methods Site-directed mutagenesis method based on overlap extension PCR was used to introduce mutations in the two sites which were E292V and M723I in the ABCA3. The PCR fragments were subcloned to PEGFP-C2 vectors to construct the eukaryotic green fluorescent protein expression rectors. A549 cells were transiently transfected with the recombinants using Lipofectamine 2000 and the transfection efficiency was confirmed through GFP signal. The expression and location of recombinants were detected by FV1000 laser scanning microscope. Results Direct sequence analysis confirmed an A to T transition at position 875 in E292V and a G to A transition at position 2169 in M723I. Recombinants were transfected to A549 cells and both wild type and mutant ABCA3 proteins were expressed in the cytoplasm. Conclusions The eukaryotic green fluorescent protein expression rectors of wild type and mutant ABCA3 gene were constructed and they were successfully expressed in A549 cells. This experiment provides a basis for subsequent research.
WANG Juan-Juan,LI Yuan,CHEN Chun-Yan et al. Site-directed mutagenesis and protein expression of ABCA3 gene in A549 cells[J]. CJCP, 2015, 17(4): 395-399.
Shulenin S, Nogee LM, Annilo T, et al. ABCA3 gene mutations in newborns with fatal surfactant deficiency[J]. N Eng J Med, 2004, 350(13): 1296-1303.
[2]
Cheong N, Madesh M, Gonzales LW, et al. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome[J]. J Biol Chem, 2006, 281(14): 9791-9800.
Cheong N, Zhang H, Madesh M, et al. Abca3 is critical for lamellar body biogenesis in vivo[J]. J Biol Chem, 2007, 282(33): 23811-23817.
[5]
Gonçalves JP, Pinheiro L, Costa M, et al. Novel ABCA3 mutations as a cause of respiratory distress in a term newborn[J]. Gene, 2014, 534(2): 417-420.
[6]
Flamein F, Riffault L, Muselet-Charlier C, et al. Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children[J]. Hum Mol Genet, 2012, 21(4): 765-775.
[7]
Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2010 update[J]. Neonatology, 2010, 97(4): 402-417.
[8]
Hamvas A. Evaluation and management of inherited disorders of surfactant metabolism[J]. Chin Med J (Engl), 2010, 123(20): 2943-2947.
[9]
Agrawal A, Hamvas A, Cole FS, et al. An intronic ABCA3 mutation that is responsible for respiratory disease[J]. Pediatr Res, 2012, 71(6): 633-637.
[10]
Weichert N, Kaltenborn E, Hector A, et al. Some abca3 mutations elevate er stress and initiate apoptosis of lung epithelial cells[J]. Respir Res, 2011, 12: 4.
[11]
Matsumura Y, Ban N, Ueda K, et al. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency[J]. J Biol Chem, 2006, 281(45): 34503-34514.
[12]
Matsumura Y, Ban N, Inagaki N. Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 295(4): L698-L707.
